Korhan ERKANLI, Burak ERSOY, İhsan BAKIR, Burak ONAN, İsmihan Selen ONAN, İbrahim Faruk AKTÜRK

Clinical outcomes of mitral valve repair: a single-center experience in 100 patients

Amaç: Çalışmamızda mitral yetersizlik (MY) ve mitral darlık için uygulanan kapak tamirlerinin klinik sonuçları değerlendirildi.Çalışma planı: Bu klinik çalışmaya, mitral tamir uygulanan ardışık ilk 100 hasta (46 erkek, 54 kadın; ort. yaş 52.1±15.5 yıl; dağılım 16-77 yıl) dahil edildi. Patolojiler romatizmal (n=44), iskemik (n=30), miksomatöz (n=29) ve korda rüptürü (n=7) idi. Mitral anüloplasti halkası rutin olarak kullanıldı. Hastaların %79'una eş zamanlı işlemler uygulandı; koroner arter baypas greftleme (n=35) ve triküspid halka anüloplasti (n=34). Ameliyat sonrası komplikasyonlar kaydedildi. Ekokardiyografik incelemeler taburcu sırasında ve klinik takip sürecinde yapıldı. Kaplan-Meier analizi genel sağkalım ve rezidüel ciddi MY, tromboembolizasyon, endokardit ve tekrar ameliyatsız sağkalım oranlarının tahmininde kullanıldı.Bul gu lar: Düşük kardiyak debi ve sepsis nedeniyle beş hastada erken (30 gün) mortalite gelişti. Taburculuk sırasında ekokardiyografi ile hastaların %59.5'inde eser/hiç MY, %30.8'inde hafif MY ve %5.3'ünde orta MY saptandı. Ortalama takip süresi, 94 hasta için 22.7±5.8 aydı. Takip döneminde transtorasik ekokardiyografide %96.6 hastada hafif MY izlendi. Sadece iki hastada (%2.1) endokardit ve iskemiye bağlı ciddi MY saptandı. Ortalama sol ventrikül sistol (p=0.01) ve diyastol sonu (p

Mitral kapak onarımının klinik sonuçları: 100 hastada tek merkez deneyimi

Background: In this study, we evaluated the clinical outcomes of valve repair for mitral regurgitation (MR) and mitral stenosis. Methods: This clinical study included the first 100 consecutive patients (46 males, 54 females; mean age 52.1±15.5 years; range 16 to 77 years) who underwent mitral repair. Pathologies were rheumatic (n=44), ischemic (n=30), myxomatous (n=29), and chordal rupture (n=7). Mitral annuloplasty ring was used routinely. Concomitant procedures were performed in 79% of patients including coronary artery bypass grafting (n=35) and tricuspid ring annuloplasty (n=34). Postoperative complications were recorded. Echocardiographic examinations were performed at discharge and during follow-up. Kaplan- Meier analysis was used to estimate overall survival and from residual severe MR, thromboembolization, endocarditis and reoperation-free survival rates. Results: Early (30 days) mortality developed in five patients due to low cardiac output and sepsis. At discharge, echocardiography revealed none/trivial MR in 59.5%, mild MR in 30.8%, and moderate MR in 5.3% of patients. The mean follow-up was 22.7±5.8 months in 94 patients. During follow-up, transthoracic echocardiography showed mild MR in 96.6% patients. Only two patients (2.1%) presented with severe MR due to endocarditis and ischemic disease. The mean left ventricular end-systolic (p=0.01) and end-diastolic diameters (p

PDF

___

1. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
2. Bakir I, Casselman FP, Brugada P, Geelen P, Wellens F, Degrieck I, et al. Current strategies in the surgical treatment of atrial fibrillation: review of the literature and Onze Lieve Vrouw Clinic's strategy. Ann Thorac Surg 2007;83:331-40.
3. David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg 2005;130:1242-9.
4. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 2001;104:I1-I7.
5. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Metaanalysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011;39:295-303.
6. Korkmaz AA, Onan B, Demir AS, Tarakçı SI, Gündoğdu R, Akdemir I, et al. Clinical outcomes of mitral valve repair in mitral regurgitation: a prospective analysis of 100 consecutive patients. Anadolu Kardiyol Derg 2011;11:542-50.
7. Akar AR, Durdu S, Zaim C, Baran C, Altin T, Tulunay Kaya C, et al. Clinical outcome and factors affecting surgical decision for repair versus replacement in patients with mitral regurgitation. [Article in Turkish] Anadolu Kardiyol Derg 2010;10:358-66.
8. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
9. Carpentier A. Cardiac valve surgery--the “French correction”. J Thorac Cardiovasc Surg 1983;86:323-37.
10. Durán CG, Revuelta JM, Gaite L, Alonso C, Fleitas MG. Stability of mitral reconstructive surgery at 10-12 years for predominantly rheumatic valvular disease. Circulation 1988;78:I91-6.
11. Onan B, Onan IS, Caynak B, Korkmaz AA, Sağbaş E, Sanisoğlu I, et al. Comparison of the results of irrigated monopolar and bipolar radiofrequency ablation in the surgical treatment of atrial fibrillation. [Article in Turkish] Anadolu Kardiyol Derg 2011;11:39-47.
12. Adams DH, Anyanwu AC. Seeking a higher standard for degenerative mitral valve repair: begin with etiology. J Thorac Cardiovasc Surg 2008;136:551-6.
13. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27.
14. Shahian DM, Normand SL. The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg 2003;75:1048-58.
15. David TE. Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Semin Thorac Cardiovasc Surg 2007;19:116-20.
16. Toledano K, Rudski LG, Huynh T, Béïque F, Sampalis J, Morin JF. Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol 2007;23:209-14.
17. Chauvaud S, Fuzellier JF, Berrebi A, Deloche A, Fabiani JN, Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001;104:I12-5.
18. Choudhary SK, Talwar S, Dubey B, Chopra A, Saxena A, Kumar AS. Mitral valve repair in a predominantly rheumatic population. Long-term results. Tex Heart Inst J 2001;28:8-15.
19. Braunberger E, Deloche A, Berrebi A, Abdallah F, Celestin JA, Meimoun P, et al. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 2001;104:I8-11.
20. Silberman S, Klutstein MW, Sabag T, Oren A, Fink D, Merin O, et al. Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann Thorac Surg 2009;87:1721-6.
21. Lai DT, Timek TA, Tibayan FA, Green GR, Daughters GT, Liang D, et al. The effects of mitral annuloplasty rings on mitral valve complex 3-D geometry during acute left ventricular ischemia. Eur J Cardiothorac Surg 2002;22:808-16.
22. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Metaanalysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011;39:295-303.
23. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
24. Bakir I, Onan B, Onan IS, Gul M, Uslu N. Is rheumatic mitral valve repair still a feasible alternative?: indications, technique, and results. Tex Heart Inst J 2013;40:163-9.